  0 Table of Contents |
  1 Home |
 2 Conformance |
 2.1 General Requirements |
 2.2 Declaring Conformance |
| 3 Guidance |
| 3.1 General Guidance |
| 3.2 Medicine Information |
| 3.3 Sex and Gender |
| 3.4 AUCDI |
| 3.5 Relationship With Other IGs |
| 3.6 Comparison With Other National and International IGs |
| 3.7 AU Variance Statement |
| 3.8 Future of AU Core |
| 4 Security and Privacy |
| 5 FHIR Artefacts |
| 5.1 Artefacts Summary |
| 5.1.1 AU Core Responder |
| 5.1.2 AU Core Requester |
| 5.1.3 AU Core Responder CapabilityStatement |
| 5.1.4 AU Core Requester CapabilityStatement |
| 5.1.5 AUCoreClinicalPatient |
| 5.1.6 AUCorePractitionerRolePractitioner |
| 5.1.7 AU Core AllergyIntolerance |
| 5.1.8 AU Core Condition |
| 5.1.9 AU Core DiagnosticReport |
| 5.1.10 AU Core Encounter |
| 5.1.11 AU Core Immunization |
| 5.1.12 AU Core Location |
| 5.1.13 AU Core Medication |
| 5.1.14 AU Core MedicationDispense |
| 5.1.15 AU Core MedicationRequest |
| 5.1.16 AU Core Organization |
| 5.1.17 AU Core Patient |
| 5.1.18 AU Core Practitioner |
| 5.1.19 AU Core PractitionerRole |
| 5.1.20 AU Core Procedure |
| 5.1.21 AU Core Endpoint |
| 5.1.22 AU Core DocumentReference |
| 5.1.23 AU Core Blood Pressure |
| 5.1.24 AU Core Body Height |
| 5.1.25 AU Core Body Weight |
| 5.1.26 AU Core Body Temperature |
| 5.1.27 AU Core Respiration Rate |
| 5.1.28 AU Core Heart Rate |
| 5.1.29 AU Core Waist Circumference |
| 5.1.30 AU Core HealthcareService |
| 5.1.31 AU Core Composition |
| 5.1.32 AU Core Smoking Status |
| 5.1.33 AU Core Pathology Result Observation |
| 5.1.34 AU Core Diagnostic Result Observation |
| 5.1.35 AU Core MedicationStatement |
| 5.1.36 AU Core RelatedPerson |
| 5.1.37 AU Core Sex Assigned At Birth |
| 5.1.38 AllergyIntolerance - Lactose intolerance |
| 5.1.39 AllergyIntolerance - No known allergy |
| 5.1.40 AllergyIntolerance - Penicillin allergy |
| 5.1.41 Composition - AU Patient Summary (minimal) |
| 5.1.42 Condition - Chronic Kidney Disease |
| 5.1.43 Condition - Urinary tract infection |
| 5.1.44 Condition - Data suppressed for category and code |
| 5.1.45 Condition - No known condition |
| 5.1.46 DocumentReference - AU Patient Summary (inline attachment) |
| 5.1.47 DocumentReference - AU Patient Summary (external reference) |
| 5.1.48 DiagnosticReport - Lipid panel |
| 5.1.49 DiagnosticReport - Covid-19 PCR |
| 5.1.50 Encounter - COVID 19 Vaccine Administration Dose 1 |
| 5.1.51 Encounter - Discharge |
| 5.1.52 Encounter - telehealth |
| 5.1.53 Endpoint - Bobrester Medical Center FHIR REST |
| 5.1.54 Endpoint - Mitchell's Hill Audiology SMD |
| 5.1.55 Endpoint - Murrabit Hospital HL7 v2 MLLP |
| 5.1.56 Immunization - COVID Dose 1 |
| 5.1.57 Immunization - Administration of Zoster vaccination refused |
| 5.1.58 Location - Tindal Building |
| 5.1.59 Location - Patient home |
| 5.1.60 Location - Murrabit Public Hospital |
| 5.1.61 Medication - Branded pack with one active ingredient |
| 5.1.62 Medication - Product with two active ingredients |
| 5.1.63 Medication - Simvastatin 40 MG Disintegrating Oral Tablet |
| 5.1.64 Medication - Lipex 40 mg tablet |
| 5.1.65 MedicationRequest - prescription, paracetamol 500 mg + codeine phosphate hemihydrate 30 mg |
| 5.1.66 MedicationRequest - active prescription, Reaptan |
| 5.1.67 MedicationRequest - active prescription, Simvastatin |
| 5.1.68 MedicationDispense - completed supply, Panadeine Forte tablet |
| 5.1.69 MedicationDispense - completed supply, Reaptan |
| 5.1.70 MedicationDispense - completed supply, Lipex |
| 5.1.71 MedicationStatement - active use of Bisoprolol 2.5mg |
| 5.1.72 MedicationStatement - completed use of Bactrim DS |
| 5.1.73 MedicationStatement - completed use of Chloramphenicol 1% eye ointment |
| 5.1.74 MedicationStatement - patient has taken Diflucan in the past but is not taking it any more |
| 5.1.75 Observation - Blood Pressure (systolic and diastolic) |
| 5.1.76 Observation - Blood Pressure (data absent for diastolic) |
| 5.1.77 Observation - Height |
| 5.1.78 Observation - Temperature |
| 5.1.79 Observation - Body weight |
| 5.1.80 Observation - Hearing threshold Ear (left) 500 Hz |
| 5.1.81 Observation - Heart rate |
| 5.1.82 Observation - Pulse rate |
| 5.1.83 Observation - HDL |
| 5.1.84 Observation - LDL |
| 5.1.85 Observation - Total Cholesterol/HDL ratio |
| 5.1.86 Observation - Triglyceride |
| 5.1.87 Observation - COVID Pathology Result (Not detected) |
| 5.1.88 Observation - Respiration rate |
| 5.1.89 Observation - Current smoker |
| 5.1.90 Observation - Waist Circumference |
| 5.1.91 Observation - Data suppressed for category, code, effective[x] and value[x] |
| 5.1.92 Organization - Bobrester Medical Centre |
| 5.1.93 Organization - Murrabit Public Hospital |
| 5.1.94 Organization - Mitchells Hill Audiology |
| 5.1.95 Organization - Pullabooka Pathology |
| 5.1.96 Organization - Appin Pharmacy |
| 5.1.97 Patient - Ronny Lawrence Irvine |
| 5.1.98 Patient - Mrs. Anne Bennelong |
| 5.1.99 Patient - Mr. Li Wang |
| 5.1.100 Patient - Mia Leanne Banks |
| 5.1.101 Patient - Deangelo HOWE |
| 5.1.102 Practitioner - Dr. Bob Bobrester |
| 5.1.103 Practitioner - Dr. Sallie Sutherland |
| 5.1.104 Practitioner - Megan Peterson |
| 5.1.105 Practitioner - Dr. Chau FRYER |
| 5.1.106 Practitioner - Darleen MACKAY |
| 5.1.107 PractitionerRole - General practitioner |
| 5.1.108 PractitionerRole - Cardiologist |
| 5.1.109 PractitionerRole - Pharmacist |
| 5.1.110 PractitionerRole - Surgeon |
| 5.1.111 PractitionerRole - Nephrologist |
| 5.1.112 Procedure - Dialysis |
| 5.1.113 Procedure - Stent insertion |
| 5.1.114 RelatedPerson - Father of Mia Leanne Banks |
| 5.1.115 RelatedPerson - Friend of Mr. Li Wang |
| 5.1.116 Specimen - Naso swab (COVID test) |
| 5.1.117 HealthcareService - CoreStrength Physiotherapy |
| 5.1.118 HealthcareService - Murrabit Crisis Hotline |
| 5.2 Profiles and Extensions |
| 5.3 Search Parameters |
| 5.4 Terminology |
| 5.5 Capability Statements |
| 5.6 Actor Definitions |
| 6 Examples |
| 7 Support |
| 7.1 Downloads |
| 7.2 License and Legal |
| 8 Change Log |
|
Propose a change